Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Catella - Ready to spring into action

26 augusti 2025

<a id="bm-comp-9b10dc56-c281-4ee5-aaa6-32c86f4dc93d" name="bm-comp-9b10dc56-c281-4ee5-aaa6-32c86f4dc93d" class="BMCustomAnchor"></a><table><tr><td bm-component-id="9b10dc56-c281-4ee5-aaa6-32c86f4dc93d" style="vertical-align: top; width:100.000000%;"><ul><li><font color="#000000">Q2 beat with activity picking up</font></li><li><font color="#000000">Pre-tax profit up by 13-16% for 2026-27e</font></li><li><font color="#000000">2025e-27e EV/EBIT of 4-6x with easy comps</font></li></ul></td></tr></table><a id="bm-comp-bd340c82-fc0e-4a8b-8d81-39f96c48d412" name="bm-comp-bd340c82-fc0e-4a8b-8d81-39f96c48d412" class="BMCustomAnchor"></a><table><tr><td bm-component-id="bd340c82-fc0e-4a8b-8d81-39f96c48d412" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q2'25: Second-strongest quarter ever</h3><p>Catella delivered a solid 7% earnings beat vs. FactSet consensus, with Corporate Finance standing out with a substantial earnings improvement q-o-q. The strong quarterly earnings in Q2, the second highest EBIT the company has even delivered, was driven by the divestment of the property development project Kaktus in Denmark, which contributed SEK 252m to the quarterly EBIT of SEK 315m. Following the divestment of Kaktus, Catella's cash position more than doubled q-o-q, to SEK 1.7bn (&gt;60% of the market cap). We are positive about the buyback of SEK 600m in bonds announced in conjunction with the report, as it is shareholder-friendly, improves Catella's capital efficiency and reduces interest expenses.</p><h3 class="bm-h3">AUM and buyback raises EPS by 13-17% 2026-27e</h3><p>Following the stronger than expected sequential AUM trend in Q2, our Investment Management earnings estimates are raised by 3-7%. In addition, given the bond buyback announcement, our interest cost estimates are greatly reduced. In sum, our EPS estimates are up by 40% for 2025 and 13-17% for 2026-27.</p><h3 class="bm-h3">2025-27e EV/EBIT of 4-6x with a 6-8% dividend yield</h3><p>The company has, in our view, many attractive fundamentals, including an impressive track record within Investment Management and attractive own-property investments. The balance sheet remains strong, providing Catella with the necessary resources should the right opportunities arise. The comps are easy, and we believe the transaction activity outlook is promising. This means that we expect strong yearly earnings expansion from here. In addition, when applying our latest earnings revisions, Catella is trading at an EV/EBIT of 4-6x for 2025e-27e and offers an appealing dividend yield of 6-8% p.a.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-08-14 Skolon - Timing effects to weigh on Q2 Skolon Analys
2026-08-14 NYAB - Delivering on its promises NYAB Analys
2026-08-14 BTS Group - Organic growth beat and raised guidance BTS Group Analys
2026-08-13 NYAB - Strong earnings beat, +27% vs cons NYAB Analys
2026-08-12 G5 Entertainment - Cost cuts to support earnings ... G5 Entertai.. Analys
2026-08-12 Ferronordic - Three for three Ferronordic Analys
2026-08-12 G5 Entertainment - Larger cost savings offsetting... G5 Entertai.. Analys
2026-08-12 Ferronordic - Earnings beat across the board Ferronordic Analys
2026-08-11 OssDsign - Waiting for the growth to return OssDsign Analys
2026-08-11 Arctic Paper - Pulp beats paper II Arctic Paper Analys
2026-08-11 Generic - The growth journey continues Generic Analys
2026-08-10 Donkey Republic - Q2 likely to confirm strong gro... Donkey Repu.. Analys
2026-08-06 Medicover - Divests Medicover Hospitals India Medicover Analys
2026-07-30 Byggmästaren - Private assets strong, but Green s... Byggmästaren Analys
2026-07-30 Catella - Recovery gradually taking shape Catella Analys
2026-07-24 Cavotec - Low-margin legacy orders weigh on Q2 Cavotec Analys
2026-07-24 Cavotec - P&M order momentum sustained Cavotec Analys
2026-07-22 Inission - Strong trend to continue Inission Analys
2026-07-22 SinterCast - Q2 still tough, but we see tailwinds... SinterCast Analys
2026-07-22 Medicover - No symptoms of surprise in Q2 Medicover Analys